From disposal to bioprospecting: a study on organic matter from macroalgae as a source of new carrageenans with activity against SARS-CoV-2
2023pp. 49–49
D. Souza, Amanda Resende Tucci, Alice Schaffer da Rosa, Thamara Oliveira, Vivian Ferreira, Nathalia Roberto Resende Borba, Milena Conci, Beatriz Benevides, Marcelo Maraschin, Milene Dias Miranda
Abstract
Introduction: World Health Organization (WHO) data indicate that SARS-CoV-2 infection has already caused more than 6.8 million deaths since the beginning of the COVID19 pandemic. Currently, there are only three antiviral molecules (remdesivir, tocilizumab, baricitinib) approved by the American FDA for clinical use against COVID19. Studies show that carrageenans are considered potential inhibitors of several enveloped viruses, such as SARS-CoV-2, requiring further in vitro analyzes to understand their mechanism of action.
Related Papers
- A GEOMETRIC MEAN IN THE FURUTA INEQUALITY(2002)
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- Коммуникaтивно- прaгмaтический aнaлиз дипломaтических бумaг (нa основе вербaльных нот)(2018)
- → ФОРМИРОВAНИЕ ГОТОВНОСТИ БУДУЩИХ ПЕДAГОГОВ К ОРГAНИЗAЦИИ РAБОТЫ ПО РAЗВИТИЮ ВAЛЕОЛОГИЧЕСКОЙ КУЛЬТУРЫ ШКОЛЬНИКОВ(2023)